Miguel Moreno‐Martet

Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of <scp>SOD</scp>1^G93A Transgenic Mice and Evaluation of a Sativex^®‐like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis

Miguel Moreno‐Martet, Francisco Espejo‐Porras, Javier Fernández‐Ruíz et al. · CNS Neuroscience & Therapeutics · 2014 · 90 citations · Full text

Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

Eva de Lago, Miguel Moreno‐Martet, Ana Cabranes et al. · Neuropharmacology · 2012 · 77 citations

Inflammation, Cytokine, Cannabis Use +11

A <scp>S</scp>ativex^®‐like combination of phytocannabinoids as a disease‐modifying therapy in a viral model of multiple sclerosis

Ana Feliú, Miguel Moreno‐Martet, Míriam Mecha et al. · British Journal of Pharmacology · 2015 · 69 citations · Full text

The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ-tetrahydrocannabinol acting through CB1 receptors

Miguel Moreno‐Martet, Ana Feliú, Francisco Espejo‐Porras et al. · Multiple Sclerosis and Related Disorders · 2015 · 37 citations

Neuroinflammation, Clinical Disorders, Cannabis Use +15

Cannabinoids, multiple sclerosis and neuroprotection

Eva de Lago, María Gómez‐Ruíz, Miguel Moreno‐Martet et al. · Expert Review of Clinical Pharmacology · 2009 · 19 citations

Neurological Disorder, Social Sciences, Neuroinflammation +16